江天化学(300927) - 2024 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2024 was ¥171,299,011.23, a decrease of 10.55% compared to ¥191,495,027.31 in the same period last year[15] - Net profit attributable to shareholders for Q1 2024 was ¥12,446,146.76, down 45.46% from ¥22,822,001.97 year-on-year[15] - The net profit after deducting non-recurring gains and losses was ¥12,396,405.64, reflecting a decrease of 45.18% compared to ¥22,612,641.79 in the previous year[15] - Basic earnings per share for Q1 2024 were ¥0.0862, down 45.48% from ¥0.1581 in the previous year[15] - Net profit for the current period is ¥12,446,146.76, a decline of 45.5% compared to ¥22,822,001.97 in the previous period[47] - Basic and diluted earnings per share are both ¥0.0862, down from ¥0.1581 in the previous period[48] Cash Flow - The net cash flow from operating activities was negative at -¥27,468,437.33, a decline of 242.97% from ¥19,212,911.99 in the same period last year[15] - Cash flow from operating activities shows a net outflow of ¥27,468,437.33, compared to a net inflow of ¥19,212,911.99 in the previous period[49] - The net cash inflow from investment activities was $102.18 million, compared to$40.22 million in the previous period, indicating a significant increase[37] - The net cash outflow from investment activities totaled $230.60 million, up from$180.84 million year-over-year[37] - The net cash flow from financing activities was $110.75 million, a recovery from a net outflow of$196.19 million in the previous period[37] - The total cash and cash equivalents at the end of the period were $277.46 million, down from$322.40 million at the beginning of the period[37] - The company reported a decrease in cash and cash equivalents by $44.94 million during the period, compared to a larger decrease of$121.50 million in the previous period[37] Assets and Liabilities - Total assets at the end of Q1 2024 were ¥1,184,856,320.52, an increase of 18.42% from ¥1,000,529,837.52 at the end of the previous year[15] - The total assets increased to $1.18 billion from$1.00 billion in the previous period, reflecting growth in both current and non-current assets[44] - The total current assets rose to $626.56 million, compared to$474.78 million in the previous period, showing a strong liquidity position[42] - Total liabilities amount to ¥485,091,155.01, an increase from ¥314,457,973.57 in the previous period[45] - Total equity attributable to shareholders of the parent company is ¥699,765,165.51, up from ¥686,071,863.95 in the previous period[45] Operational Efficiency - The weighted average return on net assets was 1.80%, down from 3.52% in the previous year, indicating a decline in efficiency[15] - The company reported a significant decline in sales of its formaldehyde series products, contributing to the overall decrease in profitability[24] - The company has not identified any non-recurring gains or losses that would affect its financial reporting for this period[6] - The company reported a decrease in research and development expenses to ¥1,221,823.75 from ¥1,678,504.54 in the previous period[47] - Other income for the current period is ¥62,521.50, down from ¥85,221.92 in the previous period[47] - The company recorded a credit impairment loss of ¥-316,542.88, an improvement from ¥-682,867.80 in the previous period[47] Investment Activities - The company is planning to acquire 100% equity of San Da Ya Fine Chemicals (Nantong) Co., Ltd., which will become a wholly-owned subsidiary if the transaction is completed[27] - The company’s long-term investments in fixed assets were valued at $212.14 million, down from$224.08 million in the previous period[44] - The accounts receivable increased to $63.15 million from$58.48 million, indicating a rise in sales or credit extended to customers[42] Shareholder Information - The major shareholders include Nantong Industrial Holding Group Co., Ltd. with a 37.53% stake and Nantong Xinyuan Investment with a 15.02% stake[38]